Theresa Guo

Assistant Professor

University of California, San Diego

United States

Research Interests

Explore related searches

Professors in United States Professors in Cancer Biology Cancer Biology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Theresa Guo is an Assistant Professor at the University of California, San Diego, USA. Her research focuses on head and neck cancer, particularly the mechanisms of chemotherapy resistance and targeted immunotherapy strategies. Recent publications include studies on HPV-related cancer dynamics, mutational landscapes of skin cancers, and innovative techniques for tumor identification and treatment outcomes.

Articles (17)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (4)

Sayuri Miyauchi

University of California, San Diego

UNITED STATES

View details

Stephen Lai

Professor (Dual/Adjunct)

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Loren K. Mell

University of California, San Diego

UNITED STATES

View details

Hannah Carter

Associate Professor

University of California, San Diego

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Theresa Guo

Research Interests

Explore related searches

Contact this professor

About

Articles (17)

HPV E5 Mediates Resistance to Chemotherapy and Radiation by Promoting a Stem Cell–Like Phenotype in Head and Neck Squamous Cell Carcinoma

Indisulam Shows an Anti-Cancer Effect on HPV+ and HPV− Head and Neck Cancer

The Mutational and Microenvironmental Landscape of Cutaneous Squamous Cell Carcinoma: A Review

Factors associated with total laryngectomy following organ‐preserving treatment of laryngeal SCC

Factors associated with unknown primary status in head and neck squamous cell carcinoma

Identifying Strong Neoantigen MHC-I/II Binding Candidates for Targeted Immunotherapy with SINE

Fluorescent Guided Sentinel Lymph Mapping of the Oral Cavity with Fluorescent‐Labeled Tilmanocept

A Network Landscape of HPVOPC Reveals Methylation Alterations as Significant Drivers of Gene Expression via an Immune-Mediated GPCR Signal

Insurance Status is Associated With Recurrence in Cutaneous Head and Neck Squamous Cell Carcinoma

Early Improved Functional Outcomes in Head and Neck Cancer Patients with Primary Tumor Detection

Role of sentinel lymph node biopsy for oral squamous cell carcinoma: Current evidence and future challenges

OutSplice: A Novel Tool for the Identification of Tumor-Specific Alternative Splicing Events

Necrotizing Tracheitis Complicated by Tracheal Wall Perforation.

Current perspectives on recurrent HPV-mediated oropharyngeal cancer.

Thyroid Carcinoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.

Extrachromosomal DNA in HPV-Mediated Oropharyngeal Cancer Drives Diverse Oncogene Transcription.

Outcomes of patients with oropharyngeal squamous cell carcinoma treated with induction chemotherapy followed by concurrent chemoradiation compared with those treated with concurrent chemoradiation

Collaborators (4)

Sayuri Miyauchi

Stephen Lai

Loren K. Mell

Hannah Carter

Make your next move.